Jun 24, 2024 05:58PM
Aug 2, 2023 08:17AM
Aug 2, 2023 08:17AM
Jul 17, 2023 04:07PM
Jul 17, 2023 04:05PM
Jul 12, 2023 08:03AM
Jul 12, 2023 08:00AM Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
Jun 20, 2023 08:00AM
Jun 20, 2023 08:00AM
Jun 8, 2023 04:05PM
May 31, 2023 08:04AM
May 31, 2023 08:00AM
Mar 31, 2023 07:00PM
Mar 13, 2023 08:01AM Aridis Pharmaceuticals (ARDS) Reports AR-501 Met Primary and Secondary Endpoints in Phase 2a Study
Mar 13, 2023 08:00AM
Jan 25, 2023 04:28PM
Jan 25, 2023 04:05PM
Dec 12, 2022 08:05AM
Dec 12, 2022 08:05AM
Dec 12, 2022 07:06AM
Dec 12, 2022 07:00AM Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
Dec 12, 2022 07:00AM
Nov 30, 2022 07:00AM
Nov 30, 2022 07:00AM
Nov 21, 2022 06:30PM
Nov 21, 2022 06:30PM
Oct 4, 2022 08:00AM
Aug 16, 2022 04:15PM Aridis Pharmaceuticals Announces Second Quarter 2022 Financial Results and Business Update
Jun 3, 2022 08:00AM
May 16, 2022 04:05PM
Mar 31, 2022 06:04PM
Nov 10, 2021 08:00AM
Aug 12, 2021 09:00AM
Jul 13, 2021 09:25AM
Jul 12, 2021 05:59PM After-Hours Stock Movers 07/12: (PLXT) (ARDS) (EQ) Higher; (SLP) (TWO) (VOXX) Lower (more...)
May 11, 2021 04:01PM
Mar 30, 2021 05:49PM
Feb 23, 2021 06:24AM
Feb 23, 2021 05:30AM
Nov 20, 2020 04:05PM
Sep 8, 2020 06:12AM
Sep 8, 2020 05:30AM Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501
Aug 11, 2020 04:05PM
Jun 22, 2020 06:04AM
Jun 22, 2020 05:30AM
May 12, 2020 04:05PM
Apr 8, 2020 04:59PM
Nov 13, 2019 04:05PM
Aug 12, 2019 04:05PM Aridis Pharmaceuticals Announces Second Quarter 2019 Results
Jul 19, 2019 05:34AM

322,964 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All